Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec 15;204(12):1492-1493.
doi: 10.1164/rccm.202108-1965LE.

Treatment of Pulmonary Hypertension: Is Triple Therapy Necessarily Better than Monotherapy?

Xishi Sun  1   2 , Riken Chen  3   4   5 , Xiaoyun Yao  6 , Zhenzhen Zheng  2 , Manxia Wang  2 , Chaoyu Wang  7 , Junfen Cheng  2
Affiliations
Comment

Treatment of Pulmonary Hypertension: Is Triple Therapy Necessarily Better than Monotherapy?

Xishi Sun et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply to Jin et al. and to Sun et al.
    Boucly A, Weatherald J, Savale L, Jaïs X, Montani D, Humbert M, Sitbon O. Boucly A, et al. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1494-1495. doi: 10.1164/rccm.202107-1725LE. Am J Respir Crit Care Med. 2021. PMID: 34672868 Free PMC article. No abstract available.

Comment on

  • Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.
    Boucly A, Savale L, Jaïs X, Bauer F, Bergot E, Bertoletti L, Beurnier A, Bourdin A, Bouvaist H, Bulifon S, Chabanne C, Chaouat A, Cottin V, Dauphin C, Degano B, De Groote P, Favrolt N, Feng Y, Horeau-Langlard D, Jevnikar M, Jutant EM, Liang Z, Magro P, Mauran P, Moceri P, Mornex JF, Palat S, Parent F, Picard F, Pichon J, Poubeau P, Prévot G, Renard S, Reynaud-Gaubert M, Riou M, Roblot P, Sanchez O, Seferian A, Tromeur C, Weatherald J, Simonneau G, Montani D, Humbert M, Sitbon O. Boucly A, et al. Am J Respir Crit Care Med. 2021 Oct 1;204(7):842-854. doi: 10.1164/rccm.202009-3698OC. Am J Respir Crit Care Med. 2021. PMID: 34185620

References

    1. Boucly A, Savale L, Jaïs X, Bauer F, Bergot E, Bertoletti L, et al. Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension. Am J Respir Crit Care Med . 2021;204:842–854. - PubMed
    1. Haarman MG, Lévy M, Roofthooft MTR, Douwes JM, Vissia-Kazemier TR, Szezepanski I, et al. Upfront triple combination therapy in severe paediatric pulmonary arterial hypertension. Eur Respir J . 2021;57:2001120. - PubMed
    1. D’Alto M, Badagliacca R, Argiento P, Romeo E, Farro A, Papa S, et al. Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension. Chest . 2020;157:376–383. - PubMed
    1. Momoi M, Hiraide T, Shinya Y, Momota H, Fukui S, Kawakami M, et al. Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension. Ther Adv Respir Dis . 2021;15:1753466621995048. - PMC - PubMed
    1. Stubbe B, Seyfarth HJ, Kleymann J, Halank M, Al Ghorani H, Obst A, et al. Monotherapy in patients with pulmonary arterial hypertension at four German PH centres. BMC Pulm Med . 2021;21:130. - PMC - PubMed